LCQ LCQ in Specific Patient Populations

Question 1

Has the LCQ been validated for use in patients with COPD?

Accepted Answer

Yes — validated and widely used in COPD populations

Answer

The LCQ has been validated in COPD populations and is commonly used to assess the cough-specific quality of life burden in these patients alongside disease-specific COPD tools.

Question 2

Can the LCQ be used in patients with asthma-related chronic cough?

Accepted Answer

Yes — it has been applied in asthmatic patients with chronic cough

Answer

The LCQ is applicable to asthma patients with chronic cough, capturing cough-related quality of life impacts independent of the underlying diagnosis.

Question 3

Is the LCQ validated for pediatric patients?

Accepted Answer

No — it was developed and validated for adults

Answer

The LCQ was developed and validated for use in adults; separate pediatric cough quality of life tools exist for children.

Question 4

In patients with idiopathic chronic cough (ICC), what LCQ scores are typically observed?

Accepted Answer

Markedly reduced scores indicating significant quality of life impairment

Answer

Patients with idiopathic chronic cough typically demonstrate markedly reduced LCQ scores across all three domains, reflecting profound quality of life impairment.

Question 5

How has the LCQ been used in patients with chronic cough secondary to gastroesophageal reflux (GERD)?

Accepted Answer

To monitor quality of life changes as reflux treatment is adjusted

Answer

In GERD-related cough, the LCQ is used as an outcome measure to track quality of life improvement as anti-reflux therapy is optimized.

LCQ - Leicester Cough Questionnaire Practice Test

LCQ - Leicester Cough Questionnaire Practice Test

LCQ LCQ in Specific Patient Populations